Informações:
Falhas:
ID
26009
Descrição
Open-Label,Non-Randomized Trial of Cisplatin Chemotherapy in BRCA1-Positive Metastatic Breast Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01611727
Link
https://clinicaltrials.gov/show/NCT01611727
Palavras-chave
Versões (2)
- 02/10/2017 02/10/2017 -
- 04/10/2017 04/10/2017 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
4 de outubro de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility BRCA1 Mutation NCT01611727
Eligibility BRCA1 Mutation NCT01611727
- StudyEvent: Eligibility
Similar models
Eligibility BRCA1 Mutation NCT01611727
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Gender | Age | Secondary malignant neoplasm of female breast Measurable | BRCA1 Mutation Carrier
Item
female patients aged ≥ 18 years, with measurable (defined by response evaluation criteria in solid tumors (recist) criteria (14)) metastatic (stage iv) breast cancer, and who are known to carry a brca1 mutation, are eligible.
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0346993 (UMLS CUI [3,1])
C1513040 (UMLS CUI [3,2])
C3899965 (UMLS CUI [4])
C0001779 (UMLS CUI [2])
C0346993 (UMLS CUI [3,1])
C1513040 (UMLS CUI [3,2])
C3899965 (UMLS CUI [4])
Criteria Fulfill
Item
in addition, the following are required:
boolean
C0243161 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,2])
Hematologic function
Item
adequate hematologic
boolean
C0221130 (UMLS CUI [1])
Renal function | Liver function
Item
renal, and hepatic function
boolean
C0232804 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0232741 (UMLS CUI [2])
Operative Surgical Procedures Recent Patient recovered | Therapeutic radiology procedure Recent Patient recovered
Item
adequate recovery from recent surgery and/or radiation therapy
boolean
C0543467 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C1115804 (UMLS CUI [1,3])
C1522449 (UMLS CUI [2,1])
C0332185 (UMLS CUI [2,2])
C1115804 (UMLS CUI [2,3])
C0332185 (UMLS CUI [1,2])
C1115804 (UMLS CUI [1,3])
C1522449 (UMLS CUI [2,1])
C0332185 (UMLS CUI [2,2])
C1115804 (UMLS CUI [2,3])
Toxicity Due to Therapeutic procedure CTCAE Grades | Patient recovered | Exception Alopecia
Item
recovery from all prior treatment-related toxicities (to grade < 2 according to national cancer institute common toxicity criteria, version3.0, except alopecia)
boolean
C0600688 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C1516728 (UMLS CUI [1,4])
C1115804 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0002170 (UMLS CUI [3,2])
C0678226 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C1516728 (UMLS CUI [1,4])
C1115804 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0002170 (UMLS CUI [3,2])
Life Expectancy
Item
life expectancy of at least 12 weeks
boolean
C0023671 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status of 0 or 1. -
boolean
C1520224 (UMLS CUI [1])
Chemotherapy Quantity Neoplasm Metastasis
Item
patients could have received up to four prior chemotherapies for metastatic disease.
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
Metastatic malignant neoplasm to brain
Item
patients with known brain metastases are not eligible.
boolean
C0220650 (UMLS CUI [1])
Chemotherapy Platinum Based
Item
patients previously treated with a platinum-based chemotherapy are not eligible.
boolean
C0392920 (UMLS CUI [1,1])
C0032207 (UMLS CUI [1,2])
C1705938 (UMLS CUI [1,3])
C0032207 (UMLS CUI [1,2])
C1705938 (UMLS CUI [1,3])